Cytokinetics, Incorporated (CYTK)

NMS – Real Time Price. Currency in USD

76.98

+0.53 (0.69%)

Market open: Aug 12, 2026, 10:19 AM EDT

76.67

+0.22 (0.29%)

Previous after-hours: Aug 11, 2026, 7:35 PM EDT

07.08.2026

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

CYTK tops Q2 revenue estimates as Myqorzo gains traction, but higher launch costs and the absence of milestone payments weigh on results.

07.08.2026

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

07.08.2026

Cytokinetics Q2 Earnings Call Highlights

Cytokinetics NASDAQ: CYTK reported second-quarter results marked by early commercial momentum for MYQORZO, international market-access progress and plans to seek an expanded indication for aficamten in non-obstructive hypertrophic cardiomyopathy, or nHCM.

06.08.2026

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Cytokinetics (CYTK) came out with a quarterly loss of $1.5 per share versus the Zacks Consensus Estimate of a loss of $1.63. This compares to a loss of $1.12 per share a year ago.

Videos

No Data

There is no data to display

Cytokinetics, Incorporated (CYTK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cytokinetics, Incorporated (CYTK)

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

Cytokinetics Q2 Earnings Call Highlights

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Videos

No Data

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

Cytokinetics Q2 Earnings Call Highlights

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Videos

No Data

Search stocks

Cytokinetics, Incorporated (CYTK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cytokinetics, Incorporated (CYTK)

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

Cytokinetics Q2 Earnings Call Highlights

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Videos

No Data

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

Cytokinetics Q2 Earnings Call Highlights

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Videos

No Data